The Board of Poly Medicure at its meeting held on 22 July 2024 has approved the appointment of Vimal Bhandari (DIN : 0001318) as an Additional- Non Executive, Independent Director of the Company, with effect from 22 July 2024, subject to the approval of the shareholder at the ensuing general meeting of the Company.Powered by Capital Market - Live News

Net profit of Poly Medicure rose 18.09% to Rs 74.04 crore in the quarter ended June 2024 as against Rs 62.70 crore during the previous quarter ended June 2023. Sales rose 19.93% to Rs 384.78 crore in the quarter ended June 2024 as against Rs 320.83 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales384.78320.83 20 OPM %27.0127.18 - PBDT118.1198.57 20 PBT98.4683.04 19 NP74.0462.70 18 Powered by Capital Market - Live News

Poly Medicure will hold a meeting of the Board of Directors of the Company on 22 July 2024.Powered by Capital Market - Live News

Poly Medicure will hold a meeting of the Board of Directors of the Company on 29 June 2024.Powered by Capital Market - Live News

Net profit of Poly Medicure rose 16.24% to Rs 68.36 crore in the quarter ended March 2024 as against Rs 58.81 crore during the previous quarter ended March 2023. Sales rose 23.21% to Rs 378.07 crore in the quarter ended March 2024 as against Rs 306.85 crore during the previous quarter ended March 2023.For the full year,net profit rose 44.05% to Rs 258.26 crore in the year ended March 2024 as against Rs 179.28 crore during the previous year ended March 2023. Sales rose 23.36% to Rs 1375.80 crore in the year ended March 2024 as against Rs 1115.23 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales378.07306.85 23 1375.801115.23 23 OPM %25.5527.12 -26.0423.80 - PBDT108.6689.94 21 408.20294.66 39 PBT92.4675.16 23 344.27237.49 45 NP68.3658.81 16 258.26179.28 44 Powered by Capital Market - Live News